SCHEMBL26639107

SCHEMBL26639107

Cn1nc(-c2nccs2)cc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.44
▸ GRN P28799 1/20 0.44
▸ SORT1 Q99523 1/20 0.44
▸ STIM1 Q13586 2/20 0.43
▸ ORAI1 Q96D31 2/20 0.43
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ECE1 P42892 1/20 0.38
▸ SMPD3 Q9NY59 1/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ PHGDH O43175 3/20 0.36
▸ PDE11A Q9HCR9 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15265584 0.78 KDM4E (0.43) KDM4EGRNSORT1CA12CA1
SCHEMBL21241203 0.76 PDE10A (0.40) STIM1ORAI1SMPD3PDPK1ADORA2A
SCHEMBL26659258 0.74 KDM4E (0.49) KDM4EGRNSORT1CA12CA1
SCHEMBL768868 0.74 SMPD3 (0.42) STIM1ORAI1SMPD3PDPK1HSP90AA1
SCHEMBL22951305 0.72 STIM1 (0.37) STIM1ORAI1SMPD3PDPK1ADORA2A
SCHEMBL6494629 0.71 KDM4E (0.51) KDM4EGRNSORT1CA12CA1
SCHEMBL26638882 0.71 KDM4A (0.48) KDM4EGRNSORT1CA12CA1
SCHEMBL26639095 0.71 KDM4E (0.42) KDM4EGRNSORT1CA12CA1
SCHEMBL30722885 0.70 PTPN1 (0.50) KDM4EGRNSORT1CA12CA1
SCHEMBL22619824 0.70 KDM4E (0.50) KDM4EGRNSORT1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 — — US disclosed
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — US disclosed
WO-2023220225-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS NHERF1, ACE, METAP1 KDM4E 4022/4885GRN 3340/4885SORT1 1965/4885
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus NHERF1, ZC3HAV1, SARS1 KDM4E 3725/4885GRN 3676/4885SORT1 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback